2019 Expert opinion on biological treatment use in inflammatory bowel disease management

Toruner, MuratAkpinar, HaleAkyuz, FilizDagli, UlkuHamzaoglu, Hulya OverTezel, AhmetUnsal, Belkis2024-06-122024-06-1220192148-5607https://doi.org/10.5152/tjg.2019.061119https://hdl.handle.net/20.500.14551/24986[Abstract Not Available]en10.5152/tjg.2019.061119info:eu-repo/semantics/openAccessEvidence-Based ConsensusSevere Ulcerative-ColitisTumor-Necrosis-FactorAnti-Tnf TherapyActive Crohns-DiseaseMaintenance TherapyDouble-Blind5-Aminosalicylic AcidControlled-TrialHepatitis-B2019 Expert opinion on biological treatment use in inflammatory bowel disease managementArticle30S913S946Q4WOS:0005044277000012-s2.0-8507990441232207688Q3